Cancer Medicine

Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences.

Publisher
Wiley
Website
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2045-7634

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Biomarkers dramatically improve success rates of new cancer drugs

In recent decades there have been some big advances in developing new cancer medicines, such as Herceptin, the targeted drug to treat women diagnosed with HER2-positive breast cancer. Despite these successes, cancer remains ...

Oncology & Cancer

Factors associated with suicide in leukemia identified

(HealthDay)—Male sex, older age at diagnosis, White race, and having acute myeloid leukemia are risk factors associated with suicide among patients with leukemia, according to a study published online Oct. 6 in Cancer Medicine.

Oncology & Cancer

Outcomes equal for AYA Hodgkin therapy at peds, adult centers

(HealthDay)—For adolescent and young adult (AYA) patients with Hodgkin lymphoma (HL), treatment strategies differ, but outcomes are equivalent with treatment at pediatric and adult centers, according to a study published ...

Medications

Statins may lower mortality in high-risk prostate cancer patients

Among high-risk prostate cancer patients—those with high PSA and Gleason scores of 8 or more—many will develop a difficult-to-treat disease. Preliminary research suggests that two commonly prescribed medications, cholesterol-lowering ...

Oncology & Cancer

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 15 in Cancer Medicine.

Oncology & Cancer

High response seen for chemo in seniors with high-risk AML

(HealthDay)—A substantial proportion of older patients with high-risk acute myeloid leukemia (AML) treated with chemotherapy are long-term survivors, according to research published online June 7 in Cancer Medicine.

page 1 from 3